Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Unknown 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 10Venous Thromboembolism 7Venous Thrombosis 3Treatment of Venous Thromboembolism in Cancer Patients 3Pulmonary Embolism 3Upper Extremity Deep Vein Thrombosis 2Thrombosis 1Recurrence 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Myeloproliferative Disorders 1Lung Neoplasms 1Hemorrhage 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dalteparin 7apixaban 5edoxaban 4Rivaroxaban 3Enoxaparin 3Tinzaparin 2Heparin 2Fondaparinux 2Dabigatran 2calcium heparin 1bemiparin 1Warfarin 1Ultrasonography, Doppler, Duplex 1Rosuvastatin Calcium 1Nadroparin 1Heparin, Low-Molecular-Weight 1Data Collection 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Venous Thrombosis × Rivaroxaban × Clear all
NCT02742623 2023-11-07

COSIMO

Bayer

Completed
528 enrolled

Neoplasms, Pulmonary Embolism, Venous Thrombosis

NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01999179 2022-05-18

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Medical College of Wisconsin

Phase NA Completed
27 enrolled 8 charts

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡